BioMarin Pharmaceutical Acquires Zystor Therapeutics for $115,000,000

  • Feed Type
  • Date
    8/17/2010
  • Company Name
    Zystor Therapeutics
  • Mailing Address
    10437 Innovation Drive Milwaukee, WI 53226-4838
  • Company Description
    ZyStor Therapeutics, Inc. is a biotechnology company developing innovative therapeutics that will significantly improve the lives of patients who suffer from genetic disorders known as lysosomal storage diseases (LSDs.
  • Website
    http://www.zystor.com
  • Transaction Type
    M&A
  • Transaction Amount
    $115,000,000
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    Under the terms of the agreement, BioMarin acquired ZyStor for $22 million upfront and up to an additional $93 million if certain development, regulatory and commercial milestones are achieved.

By posting a comment, you agree to our terms and conditions.